Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Ernexa Therapeutics (ERNA) over the last 16 years, with Q3 2025 value amounting to $116000.0.

  • Ernexa Therapeutics' Other Non-Current Assets fell 333.33% to $116000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $116000.0, marking a year-over-year decrease of 333.33%. This contributed to the annual value of $118000.0 for FY2024, which is 9712.2% down from last year.
  • According to the latest figures from Q3 2025, Ernexa Therapeutics' Other Non-Current Assets is $116000.0, which was down 333.33% from $117000.0 recorded in Q2 2025.
  • Ernexa Therapeutics' 5-year Other Non-Current Assets high stood at $4.1 million for Q4 2023, and its period low was $116000.0 during Q3 2025.
  • In the last 5 years, Ernexa Therapeutics' Other Non-Current Assets had a median value of $517174.0 in 2021 and averaged $1.8 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 87268.41% in 2023, then plummeted by 9714.29% in 2025.
  • Over the past 5 years, Ernexa Therapeutics' Other Non-Current Assets (Quarter) stood at $519467.0 in 2021, then soared by 688.31% to $4.1 million in 2022, then increased by 0.12% to $4.1 million in 2023, then tumbled by 97.12% to $118000.0 in 2024, then decreased by 1.69% to $116000.0 in 2025.
  • Its Other Non-Current Assets stands at $116000.0 for Q3 2025, versus $117000.0 for Q2 2025 and $118000.0 for Q1 2025.